冠状动脉疾病管理的最新情况:一篇综述文章
Archit Bansal1, Kishore Hiwale1
1Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus
|January 17, 2024
概括
冠状动脉疾病 (CAD) 管理正在推进新的诊断,药物和程序. 以患者为中心的方法,结合生活方式的改变和心脏康复,改善了心血管健康的结果.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
- 医学研究 医学研究
背景情况:
- 冠状动脉疾病 (CAD) 是由于动脉狭窄和阻塞而带来的全球健康挑战.
- CAD并发症包括心脏病发作和心力衰竭,影响个人和医疗保健系统.
- 在理解和管理CAD方面的进步是由合作研究和临床努力推动的.
研究的目的:
- 对治疗冠状动脉疾病的创新治疗方法和临床实践中的最新趋势进行审查.
- 探索新的诊断技术,制药领域的突破,以及在CAD护理中的精准医学.
- 检查侵入性手术,生活方式修改和心脏康复方面的进展,以改善患者的治疗结果.
主要方法:
- 关于最近在CAD诊断和治疗方面的进展的文献综述.
- 对针对血小板疾病,脂质降低和心痛的新型药物的分析.
- 评估穿皮冠状动脉干预 (PCI) 和冠状动脉旁路移植 (CABG) 技术.
- 评估生活方式变化和心脏康复计划的作用.
主要成果:
- 新的诊断工具提高了早期检测和CAD的风险分层.
- 新药和精准医学提供了量身定制的治疗策略.
- 在PCI和CABG的创新已经改善了复血管化和长期结果.
- 生活方式干预和心脏康复对于患者的康复和生活质量至关重要.
结论:
- 目前的CAD管理整合了先进的诊断,药物,干预程序和生活方式干预.
- 以患者为中心的方法,包括多学科的护理,对于减少CAD的影响至关重要.
- 目前正在进行的研究继续推动心血管健康的创新治疗和护理模式的发展.
更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
5.0K
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
3.9K
相关概念视频
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...